CN113559131A - 一种用于改善肠胃的益生菌粉 - Google Patents
一种用于改善肠胃的益生菌粉 Download PDFInfo
- Publication number
- CN113559131A CN113559131A CN202110837570.6A CN202110837570A CN113559131A CN 113559131 A CN113559131 A CN 113559131A CN 202110837570 A CN202110837570 A CN 202110837570A CN 113559131 A CN113559131 A CN 113559131A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus
- stomach
- intestines
- probiotic
- improving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 33
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 33
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 24
- 210000000936 intestine Anatomy 0.000 title claims abstract description 19
- 210000002784 stomach Anatomy 0.000 title claims abstract description 19
- 239000000843 powder Substances 0.000 title claims abstract description 13
- 235000015203 fruit juice Nutrition 0.000 claims abstract description 11
- 241000894006 Bacteria Species 0.000 claims abstract description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 7
- 229920001202 Inulin Polymers 0.000 claims abstract description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 7
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 7
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 7
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 7
- 239000008103 glucose Substances 0.000 claims abstract description 7
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 7
- 229940029339 inulin Drugs 0.000 claims abstract description 7
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 7
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 6
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 6
- 241001134770 Bifidobacterium animalis Species 0.000 claims abstract description 4
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 4
- 244000199866 Lactobacillus casei Species 0.000 claims abstract description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims abstract description 4
- 241000186605 Lactobacillus paracasei Species 0.000 claims abstract description 4
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 4
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 4
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 4
- 229940118852 bifidobacterium animalis Drugs 0.000 claims abstract description 4
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 4
- 229960001031 glucose Drugs 0.000 claims abstract description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims abstract description 4
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 4
- 229940001882 lactobacillus reuteri Drugs 0.000 claims abstract description 4
- 229930003231 vitamin Natural products 0.000 claims abstract description 4
- 235000013343 vitamin Nutrition 0.000 claims abstract description 4
- 239000011782 vitamin Substances 0.000 claims abstract description 4
- 229940088594 vitamin Drugs 0.000 claims abstract description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 235000021022 fresh fruits Nutrition 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 230000036039 immunity Effects 0.000 abstract description 7
- 210000000987 immune system Anatomy 0.000 abstract description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract description 2
- 235000013361 beverage Nutrition 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 241000186012 Bifidobacterium breve Species 0.000 description 2
- 241000590002 Helicobacter pylori Species 0.000 description 2
- 201000010538 Lactose Intolerance Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229940037467 helicobacter pylori Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000193171 Clostridium butyricum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开一种用于改善肠胃的益生菌粉，包括以下几种原料：益生菌、葡萄糖、麦芽糊精、菊粉、维生素、果汁提取物；其中，所述益生菌由鼠李糖乳杆菌、干酪乳杆菌、嗜酸乳杆菌、长双歧杆菌、动物双歧杆菌、罗伊氏乳杆菌、植物乳杆菌、乳酸双歧杆菌、副干酪乳杆菌中的一种或几种组成；本发明公开一种用于改善肠胃的益生菌粉够有效的调整肠胃的免疫系统，改善肠胃内的菌群平衡系统，提高人体的免疫力；通过果汁提取物的添加，改善了益生菌的口感，便于服用。
Description
技术领域
本发明涉及益生菌技术领域，具体涉及一种用于改善肠胃的益生菌粉。
背景技术
益生菌是一类对宿主有益的活性微生物，是定植于人体肠道、生殖系统内，能产生确切健康功效从而改善宿主微生态平衡、发挥有益作用的活性有益微生物的总称。人体、动物体内有益的细菌或真菌主要有：酪酸梭菌、乳酸菌、双歧杆菌、嗜酸乳杆菌、放线菌、酵母菌等。目前世界上研究的功能最强大的产品主要是以上各类微生物组成的复合活性益生菌，其广泛应用于生物工程、工农业、食品安全以及生命健康领域。
现代社会生活忙碌，工作压力大，不少人会有三餐不定时，饮食营养不均衡的问题，因而导致肠胃功能不佳，出现腹泻、便秘、呕吐、腹痛、消化不良、消瘦等症状，影响人的免疫系统，不同程度影响人的身体健康。目前，市场上用于肠道的制剂很多，有西药、中药和保健食品，西药副作用大，中药气味更难闻，保健食品起效慢时间长。
发明内容
本发明的目的就在于解决上述问题，而提供一种用于改善肠胃的益生菌粉。
本发明通过以下技术方案来实现上述目的，一种用于改善肠胃的益生菌粉，包括以下几种原料：益生菌、葡萄糖、麦芽糊精、菊粉、维生素、果汁提取物；
其中，所述益生菌由鼠李糖乳杆菌、干酪乳杆菌、嗜酸乳杆菌、长双歧杆菌、动物双歧杆菌、罗伊氏乳杆菌、植物乳杆菌、乳酸双歧杆菌、副干酪乳杆菌中的一种或几种组成。
优选的，所述果汁提取物由新鲜水果提取制作而成。
优选的，各原料组成的质量分数比为：益生菌35-60％、葡萄糖5-15％、麦芽糊精8-20％、菊粉5-15％、维生素C5-15％、果汁提取物10-25％。
本发明的有益效果是：
本发明用于改善肠胃的益生菌粉，够有效的调整肠胃的免疫系统，改善肠胃内的菌群平衡系统，提高人体的免疫力；通过果汁提取物的添加，改善了益生菌的口感，便于服用；其中，乳双歧杆菌，用于减少乳糖不耐受，提高免疫活性，维持大肠健康，肠内菌丛正常，抑制胆固醇在肠胃的堆积；嗜酸乳杆菌：用于肠健康(腹泻等)，抗炎，IBS，调节免疫力；短双歧杆菌：用于呈状作用，增加免疫活性，抵抗幽门螺旋杆菌。
具体实施方式
下面将结合本发明实施例，对本发明技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
本实施例中，一种用于改善肠胃的益生菌粉，包括以下几种原料：益生菌、葡萄糖、麦芽糊精、菊粉、维生素、果汁提取物；
其中，所述益生菌由鼠李糖乳杆菌、干酪乳杆菌、嗜酸乳杆菌、长双歧杆菌、动物双歧杆菌、罗伊氏乳杆菌、植物乳杆菌、乳酸双歧杆菌、副干酪乳杆菌中的一种或几种组成。
所述果汁提取物由新鲜水果提取制作而成。
各原料组成的质量分数比为：益生菌35-60％、葡萄糖5-15％、麦芽糊精 8-20％、菊粉5-15％、维生素C5-15％、果汁提取物10-25％。
本发明一种用于改善肠胃的益生菌粉，够有效的调整肠胃的免疫系统，改善肠胃内的菌群平衡系统，提高人体的免疫力；通过果汁提取物的添加，改善了益生菌的口感，便于服用；其中，乳双歧杆菌，用于减少乳糖不耐受，提高免疫活性，维持大肠健康，肠内菌丛正常，抑制胆固醇在肠胃的堆积；嗜酸乳杆菌：用于肠健康(腹泻等)，抗炎，IBS，调节免疫力；短双歧杆菌：用于呈状作用，增加免疫活性，抵抗幽门螺旋杆菌。
于本领域技术人员而言，显然本发明不限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外，应当理解，虽然本说明书按照实施方式加以描述，但并非每个实施方式仅包含一个独立的技术方案，说明书的这种叙述方式仅仅是为清楚起见，本领域技术人员应当将说明书作为一个整体，各实施例中的技术方案也可以经适当组合，形成本领域技术人员可以理解的其他实施方式。
Claims (3)
1.一种用于改善肠胃的益生菌粉，其特征在于，包括以下几种原料：益生菌、葡萄糖、麦芽糊精、菊粉、维生素、果汁提取物；
其中，所述益生菌由鼠李糖乳杆菌、干酪乳杆菌、嗜酸乳杆菌、长双歧杆菌、动物双歧杆菌、罗伊氏乳杆菌、植物乳杆菌、乳酸双歧杆菌、副干酪乳杆菌中的一种或几种组成。
2.根据权利要求1所述的一种用于改善肠胃的益生菌粉，其特征在于：所述果汁提取物由新鲜水果提取制作而成。
3.根据权利要求1所述的一种用于改善肠胃的益生菌粉，其特征在于：各原料组成的质量分数比为：益生菌35-60％、葡萄糖5-15％、麦芽糊精8-20％、菊粉5-15％、维生素C5-15％、果汁提取物10-25％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110837570.6A CN113559131A (zh) | 2021-07-23 | 2021-07-23 | 一种用于改善肠胃的益生菌粉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110837570.6A CN113559131A (zh) | 2021-07-23 | 2021-07-23 | 一种用于改善肠胃的益生菌粉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113559131A true CN113559131A (zh) | 2021-10-29 |
Family
ID=78166794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110837570.6A Pending CN113559131A (zh) | 2021-07-23 | 2021-07-23 | 一种用于改善肠胃的益生菌粉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113559131A (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114642262A (zh) * | 2022-03-18 | 2022-06-21 | 杭州御寿生物科技有限公司 | 抗幽益生菌组合物及其制品和制造方法 |
| CN115844018A (zh) * | 2022-12-07 | 2023-03-28 | 晏龙国科(山东)生命科技有限公司 | 一种用于改善肠胃的益生菌粉 |
| WO2023237681A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237680A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237677A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237673A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101678054A (zh) * | 2007-05-18 | 2010-03-24 | 雀巢产品技术援助有限公司 | 在外科手术前和/或外科手术后环境中的益生菌 |
| CN110051003A (zh) * | 2019-04-24 | 2019-07-26 | 广州能靓生物技术有限公司 | 一种复合益生菌组合物及其应用 |
| CN110179120A (zh) * | 2018-02-22 | 2019-08-30 | 杨涵 | 一种提高免疫力降三高的益生菌果蔬酵素玉米肽复合膳食 |
-
2021
- 2021-07-23 CN CN202110837570.6A patent/CN113559131A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101678054A (zh) * | 2007-05-18 | 2010-03-24 | 雀巢产品技术援助有限公司 | 在外科手术前和/或外科手术后环境中的益生菌 |
| CN110179120A (zh) * | 2018-02-22 | 2019-08-30 | 杨涵 | 一种提高免疫力降三高的益生菌果蔬酵素玉米肽复合膳食 |
| CN110051003A (zh) * | 2019-04-24 | 2019-07-26 | 广州能靓生物技术有限公司 | 一种复合益生菌组合物及其应用 |
Non-Patent Citations (2)
| Title |
|---|
| KE-LIANG LI ET AL.: "Alterations of intestinal flora and the effects of probiotics in children with recurrent respiratory tract infection", 《WORLD J PEDIATR》 * |
| 李陶等: "肠道微生态调节在炎症性肠病中的应用进展", 《解放军预防医学杂志》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114642262A (zh) * | 2022-03-18 | 2022-06-21 | 杭州御寿生物科技有限公司 | 抗幽益生菌组合物及其制品和制造方法 |
| WO2023237681A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237680A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237677A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| WO2023237673A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
| CN115844018A (zh) * | 2022-12-07 | 2023-03-28 | 晏龙国科(山东)生命科技有限公司 | 一种用于改善肠胃的益生菌粉 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113559131A (zh) | 一种用于改善肠胃的益生菌粉 | |
| do Espirito Santo et al. | Influence of food matrices on probiotic viability–A review focusing on the fruity bases | |
| Mitsuoka | Development of functional foods | |
| Guan et al. | Influence of probiotic fermented fruit and vegetables on human health and the related industrial development trend | |
| Kalantzopoulos | Fermented products with probiotic qualities | |
| CN105454966A (zh) | 改善胃肠道且提高免疫力的益生菌固体饮料及其制备方法 | |
| CN109123295A (zh) | 一种益生菌固体饮料及其制备方法 | |
| CN107115364A (zh) | 一种复合益生菌及其制备方法 | |
| CN107594279A (zh) | 一种益生菌粉固体饮料及其制备方法 | |
| CN105029407A (zh) | 炎性肠病医学配方食品 | |
| Manigandan et al. | Probiotics, prebiotics and synbiotics-a review | |
| Kumari et al. | Probiotics, prebiotics, and synbiotics: Current status and future uses for human health | |
| CN111671079A (zh) | 一种复合益生菌粉组合物及其制备方法 | |
| CN104187710A (zh) | 炎性肠病全营养配方食品 | |
| CN104068303A (zh) | 一种调理肿瘤的膳食 | |
| CN104996994A (zh) | 慢性阻塞性肺疾病特定全营养配方食品 | |
| CN102869366A (zh) | 过敏性腹泻的预防和治疗 | |
| CN102300472A (zh) | 共生组合物及其制备方法 | |
| CN104256633A (zh) | 妇女延更调理全营养配方食品 | |
| CN105029392A (zh) | 鼻咽癌医学配方食品 | |
| CN104839682A (zh) | 妇女延更调理医学配方食品 | |
| CN104839657A (zh) | 肺结核医学配方食品 | |
| CN104839654A (zh) | 祛痘医学配方食品 | |
| CN104187650A (zh) | 特禀体质全营养配方食品 | |
| CN104146266A (zh) | 调理黄褐斑的全营养配方食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211029 |
|
| RJ01 | Rejection of invention patent application after publication |